DOI QR코드

DOI QR Code

Prognostic Value of Preoperative Inflammation-Based Prognostic Scores on Hospital Mortality after Gastric Cancer Surgery

  • Dinc, Tolga (Ankara Numune Teaching Hospital, General Surgery Clinic) ;
  • Yildiz, Baris Dogu (Ankara Numune Teaching Hospital, General Surgery Clinic) ;
  • Kayilioglu, Ilgaz (Ankara Numune Teaching Hospital, General Surgery Clinic) ;
  • Sozen, Isa (Ankara Numune Teaching Hospital, General Surgery Clinic) ;
  • Tez, Mesut (Ankara Numune Teaching Hospital, General Surgery Clinic) ;
  • Coskun, Faruk (Hitit University Faculty of Medicine, Corum Teaching Hospital)
  • Published : 2014.10.11

Abstract

Gastric cancer is the fourth most common malignancy worldwide. Poor prognosis in gastric cancer is linked with hypoalbuminemia. Previous studies demonstrated relationships between gastric cancer and chronic inflammation. The aim of this study was to assess the prognostic value of preoperative inflammation-based prognostic scores regarding hospital mortality after gastrectomy. Unlike other recent articles on the same topic; we could only verify prognostic value of prognostic nutritional index for in hospital mortality after surgery.

References

  1. Crumley AB, Stuart RC, McKernan M, McMillan DC (2010). Is hypoalbuminemia an independent prognostic factor in patients with gastric cancer? World J Surg, 34, 2393-8. https://doi.org/10.1007/s00268-010-0641-y
  2. Andreyev HJ, Norman AR, Oates J, Cunningham D (1998). Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies? Eur J Cancer, 34, 503-9. https://doi.org/10.1016/S0959-8049(97)10090-9
  3. Bugada D, Allegri M, Lavand'homme P, De Kock M, Fanelli G (2014). Inflammation-Based Scores: A New Method for Patient-Targeted Strategies and Improved Perioperative Outcome in Cancer Patients. Biomed Res Int, 2014, 1424-5.
  4. Cho IR, Park JC, Park CH, et al (2014). Pre-treatment neutrophil to lymphocyte ratio as a prognostic marker to predict chemotherapeutic response and survival outcomes in metastatic advanced gastric cancer. Gastric Cancer, 19.
  5. Fujiwara Y, Shiba H, Furukawa K, et al (2010). Glasgow prognostic score is related to blood transfusion requirements and post-operative complications in hepatic resection for hepatocellular carcinoma. Anticancer Re, 30, 5129-6.
  6. Hanahan D, Weinberg RA (2011). Hallmarks of cancer: the next generation. Cell, 144, 646-74. https://doi.org/10.1016/j.cell.2011.02.013
  7. Jiang N, Deng JY, Liu Y, et al (2014). The role of preoperative neutrophil-lymphocyte and platelet-lymphocyte ratio in patients after radical resection for gastric cancer. Biomarkers, 9, 1-8.
  8. Jung MR, Park YK, Jeong O, et al (2011). Elevated preoperative neutrophil to lymphocyte ratio predicts poor survival following resection in late stage gastric cancer. J Surg Oncol, 104, 504-10. https://doi.org/10.1002/jso.21986
  9. Kanda M, Fujii T, Kodera Y, et al (2011). Nutritional predictors of postoperative outcome in pancreatic cancer. Br J Surg, 98, 268-4. https://doi.org/10.1002/bjs.7305
  10. Lee S, Oh SY, Kim SH, et al (2013). Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy. BMC Cancer, 22, 13-350.
  11. Lin WL, Sun JL, Chang SC, et al (2014). Factors predicting survival of patients with gastric cancer. Asian Pac J Cancer Prev, 15, 5835-8. https://doi.org/10.7314/APJCP.2014.15.14.5835
  12. Ma JP, Wang Z, Lin JW, et al ( 2011). Neutrophil-lymphocyte ratio as a prognostic factor in gastric cancer. Zhonghua Wei Chang Wai Ke Za Zhi, 14, 944-7.
  13. Pinato DJ, North BV, Sharma R (2012). A novel, externally validated inflammation-based prognostic algorithm in hepatocellular carcinoma: the prognostic nutritional index (PNI). Br J Cancer, 106, 1439-45. https://doi.org/10.1038/bjc.2012.92
  14. Proctor MJ, Morrison DS, Talwar D, et al (2011). A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study. Eur J Cancer, 47, 2633-41. https://doi.org/10.1016/j.ejca.2011.03.028
  15. Qi-Ming Yu, Chuan-Ding Yu, Zhi-Qiang Ling (2012). Elevated circulating CD19 lymphocytes predict survival advantage in patients with gastric cancer. Asian Pacific J Cancer Prev, 13, 2219-4. https://doi.org/10.7314/APJCP.2012.13.5.2219
  16. Qing-Qing Li, Zhi-Hao Lu, Li Yang, et al (2014). Neutrophil count and the inflammation-based glasgow prognostic score predict survival in patients with advanced gastric cancer receiving first-line chemotherapy. Asian Pac J Cancer Prev, 15, 945-50. https://doi.org/10.7314/APJCP.2014.15.2.945